When I look at how these patches are marketed, I can see why people are drawn in
The first injection reveals individual sensitivity: allergic reactions, injection site reactions, blood pressure changes, and GI disturbance all surface within the first week
Because of these risks, informed consent is critical
Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism
Repurposing GLP-1 receptor agonists and novel dual/triple GLP-1, GIP, and glucagon agonists represent promising therapeutic strategies that have shown to be effective in targeting inflammation, tau phosphorylation, synaptic dysfunction, insulin resistance, and oxidative stress
I read the clinical trial data